Literature DB >> 12943581

Angiogenic factors in the central nervous system.

Mark R Harrigan1.   

Abstract

The past decade has seen considerable advances in the understanding of angiogenesis. Blood vessel development and growth in the central nervous system are tightly controlled processes that are regulated by angiogenic factors. Angiogenic factors have been implicated in the pathogenesis of a wide variety of disorders, including primary and metastatic brain tumors, aneurysms, arteriovenous malformations, and cavernous malformations. The potential clinical applications of angiogenesis research include inhibition of angiogenesis to control brain tumors and therapeutic angiogenesis to promote collateral blood vessel formation among patients at risk of ischemia. This article summarizes the processes of blood vessel formation in the brain, examines the angiogenic factors that are prominent in the central nervous system, reviews the clinical use of angiogenesis inhibitors, and identifies areas for future investigation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943581     DOI: 10.1227/01.neu.0000079575.09923.59

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  23 in total

Review 1.  Pathophysiology and treatment of brain AVMs.

Authors:  Ulrich Grzyska; Jens Fiehler
Journal:  Klin Neuroradiol       Date:  2009-05-15

2.  Plasma vascular endothelial growth factor and serum soluble angiopoietin receptor sTIE-2 in patients with dural arteriovenous fistulas: a pilot study.

Authors:  Joachim Klisch; Ralf Kubalek; Kai M Scheufler; Ute Zirrgiebel; Joachim Drevs; Martin Schumacher
Journal:  Neuroradiology       Date:  2005-01-14       Impact factor: 2.804

3.  Prediction of Histological Grade and Completeness of Resection of Intracranial Meningiomas: Role of Peritumoural Brain Edema.

Authors:  Kamalanathan Palaniandy; Mohammad Saffari Mohammad Haspani; Norzaini Rose Mohd Zain
Journal:  Malays J Med Sci       Date:  2017-06-30

4.  Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas.

Authors:  Gustavo Pradilla; Federico G Legnani; Giovanna Petrangolini; Pierangelo Francescato; Francesco Chillemi; Betty M Tyler; Sergio M Gaini; Henry Brem; Alessandro Olivi; Francesco DiMeco
Journal:  Neurosurgery       Date:  2005-11       Impact factor: 4.654

5.  A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.

Authors:  Morris D Groves; Vinay K Puduvalli; Susan M Chang; Charles A Conrad; Mark R Gilbert; Ivo W Tremont-Lukats; Ta-Jen Liu; Pamela Peterson; David Schiff; Timothy F Cloughesy; Patrick Y Wen; Harry Greenberg; Lauren E Abrey; Lisa M DeAngelis; Kenneth R Hess; Kathleen R Lamborn; Michael D Prados; W K Alfred Yung
Journal:  J Neurooncol       Date:  2006-09-22       Impact factor: 4.130

6.  Intratumoral hemorrhage-related differences in the expression of vascular endothelial growth factor, basic fibroblast growth factor and thioredoxin reductase 1 in human glioblastoma.

Authors:  Bulent Kaya; Onur Çiçek; Fatih Erdi; Siddika Findik; Yasar Karatas; Hasan Esen; Fatih Keskin; Erdal Kalkan
Journal:  Mol Clin Oncol       Date:  2016-08-02

7.  Selective expression of presenilin 1 in neural progenitor cells rescues the cerebral hemorrhages and cortical lamination defects in presenilin 1-null mutant mice.

Authors:  Paul H Wen; Rita De Gasperi; Miguel A Gama Sosa; Anne B Rocher; Victor L Friedrich; Patrick R Hof; Gregory A Elder
Journal:  Development       Date:  2005-08-03       Impact factor: 6.868

8.  Ischemia/Reperfusion-induced neovascularization in the cerebral cortex of the ovine fetus.

Authors:  Daniela Virgintino; Francesco Girolamo; Marco Rizzi; Nigar Ahmedli; Grazyna B Sadowska; Edward G Stopa; Jiyong Zhang; Barbara S Stonestreet
Journal:  J Neuropathol Exp Neurol       Date:  2014-06       Impact factor: 3.685

9.  Stimulatory effects of thyroid hormone on brain angiogenesis in vivo and in vitro.

Authors:  Liqun Zhang; Christiana Marie Cooper-Kuhn; Ulf Nannmark; Klas Blomgren; Hans Georg Kuhn
Journal:  J Cereb Blood Flow Metab       Date:  2009-10-28       Impact factor: 6.200

Review 10.  Stem cells tropism for malignant gliomas.

Authors:  Feng Xu; Jian-Hong Zhu
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.